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INTRODUCTION
Programmed cell death or apoptosis in all invertebrate and 
vertebrate multicellular organisms has been studied to include 
nematodes, insects, amphibians, and mammal [1-4]. Apopto-
sis is associated with characteristic morphological and bioche-
mical changes, including cell shrinkage, membrane blebbing, 
cell surface changes, and loss of mitochondrial function [5]. 
These cell membrane alterations include exposure of phospha-
tidylserine residues on the outer leaflet of the plasma mem-
brane [6]. Apoptosis also displays characteristic nuclear chang-
es. The chromatin undergoes condensation as endonucleases 
are activated and the DNA begins to fragment [5].
It was initially believed that apoptosis does not occur in uni-
cellular organisms but, to date, there is enough evidence to con-
firm that this phenomenon also occurs in single-cell organ-
isms [7,8]. The mechanisms and pathways that lead to induc-
tion or inhibition of apoptosis in Leishmania spp. are of partic-
ular interest as they will be potential targets for development 
of anti-Leishmania medications. Leishmaniasis is one of the 
significant causes of morbidity and mortality in several coun-
tries. This disease affects 12 million people and threatens addi-
tional 350 million persons worldwide [9]. Leishmaniasis is 
manifested in several forms, including visceral, mucocutane-
ous, or cutaneous. Leishmania major and L. tropica are causative 
agents of old world cutaneous leishmaniasis (CL) in Middle 
East and Iran [10,11].
Antimonial compounds, particularly meglumine antimoni-
ate are the first line drugs for the treatment of all forms of lei-
shmaniasis in Iran [12]. Recent circumstantial evidence sug-
gested that an increasing number of Iranian patients with CL 
is unresponsive to meglumine antimoniate [13]. Although 
pentavalent antimonials, paromomycin and fluconazole have 
been used in the treatment of CL, these medications have sev-
eral limitations, including resistance to pentavalent antimonial 
drugs, parenteral route of administration, long duration of 
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Abstract: The aim of this study was to assess the cytotoxic effects of various concentrations of miltefosine on Leishma-
nia major (MRHO/IR/75/ER) and L. tropica (MHOM/IR/02/Mash10) promastigotes and to observe the programmed cell 
death features. The colorimetric MTT assay was used to find L. major and L. tropica viability and the obtained results were 
expressed as 50% inhibitory concentration (IC50). Also, 50% effective doses (ED50) for L. major and L. tropica amasti-
gotes were also determined. Annexin-V FLUOS staining was performed to study the cell death properties of miltefosine 
using FACS analysis. Qualitative analysis of the total genomic DNA fragmentation was performed by agarose gel electro-
phoresis. Furthermore, to observe changes in cell morphology, promastigotes were examined using light microscopy. In 
both strains of L. major and L. tropica, miltefosine induced dose-dependent death with features of apoptosis, including 
cell shrinkage, DNA laddering, and externalization of phosphatidylserine. The IC50 was achieved at 22 µM and 11 µM for 
L. major and L. tropica after 48 hr of incubation, respectively. ED50 of L. major and L. tropica amastigotes were 5.7 μM 
and 4.2 μM, respectively. Our results indicate that miltefosine induces apoptosis of the causative agent of cutaneous lei-
shmaniasis in a dose-dependent manner. Interestingly, L. major did not display any apoptotic changes when it was ex-
posed to miltefosine in concentrations sufficient to kill L. tropica.
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treatment, and unwanted side effects [14]. Oral miltefosine 
(hexadecylphosphocholine: HePC), an antitumor agent, has 
been used for treatment of visceral leishmaniasis in India [15]. 
A number of studies have been performed to elucidate the me-
chanism of action of HePC. The antineoplastic activity of HePC 
has been attributed to its apoptosis-inducing potential [16]. 
Apoptosis has also been proposed as the mechanism of anti-
protozoal activity of this medication [17]. 
In the present study, we evaluated the dose-dependent leish-
manicidal activity of miltefosine on different causative agents 
of CL in Iran.
MATERIALS AND METHODS
Miltefosine (1-O-hexadecylphosphocholine), with the struc-
tural formula of C21H46NO4P and molecular weight of 407.57, 
were prepared from Zentaris GmbH (Zentaris, GmbH, and 
Frankfurt, Germany). MTT colorimetric assay kit was purchased 
from Sigma Chemical Co. (St. Louis, Missouri, USA). Further-
more, the Annexin-V FLUOS Staining Kit was purchased from 
Roche-applied-science (Berlin, Germany). J774 A.1 mouse ma-
crophage cell line was purchased from Pasteur Institute (Teh-
ran, Iran). L. major (MRHO/IR/75/ER) and L. tropica (MHOM/
IR/02/Mash 10) were kindly provided by Dr. Mohebali (Teh-
ran University of Medical Sciences, Tehran, Iran). 
Culture of L. major and L. tropica 
Briefly, 5×10
5 cells/ml were cultured in the RPMI 1640 me-
dia (pH 7.2, containing 25 mM HEPES) (Sigma) supplement-
ed with 10% heat inactivated fetal bovine serum and antibiot-
ics at 24˚C for 96 hr and subcultured at cell densities of 2×10
7 
to 2.5×10
7 cells/ml. After subculture, promastigotes were seed-
ed in 96-well culture plates at a density of 2×10
6 cells/ml and 
treated with HePC in final concentrations ranging from 1-100 
μM. HePC was added in triplicate at final dilutions ranging 
from 1 to 100 μM. The plates were incubated at 25˚C for 48 hr 
before MTT assay. All tests were performed in triplicates.
J774 cell line culture and inoculation with L. tropica and 
L. major for finding ED50 
To evaluate half maximal effective dose (ED50) of miltefos-
ine on the amastigotes of Leishmania, J774 cell line, cultured in 
RPMI medium (containing 10% FCS and 100 μg/ml penicil-
lin-streptomycin) at 37˚C with 5% CO2. Flasks of monolayer 
J774 cell line were prepared and inoculated with L. major and 
L. tropica strains, in a ratio of 5 parasites per macrophage. After 
4 hr incubation at 32˚C, to remove all free parasites from the 
flasks, the cells were washed 2 times. Different concentrations 
of miltefosine (1, 2.5, 5, 10, 20, and 30 μM) were added and 
flasks were incubated for 48 hr in 32˚C with 5% CO2. Each test 
was done triplicate. Microscopic slides were prepared from each 
cell suspension and stained by Giemsa (100 macrophages per 
treatment) to determine percentage of infected cells and the 
number of parasites per infected macrophage. The ED50 is de-
fined for each strain as the effective dose of miltefosine that re-
duces the survival of Leishmania parasites by 50%.
Cell viability measurements by MTT assay
MTT [3-(4, 5-methylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide] colorimetric assay is to measure reduction of MTT 
dyes (tetrazolium) into formazan by mitochondrial enzymes 
in viable cells. Relative numbers of live cells were determined 
based on the optical absorbance of the treated and untreated 
samples and blank wells using the following formula: 
Viable cells (%)=(AT-AB)/(AC-AB)×100
where AC is the absorbance of the untreated samples, AT is the 
absorbance of the treated samples, and AB is the absorban  ce of 
the blank. All values are means of triplicate wells. Results were 
expressed as the concentration that inhibited parasite grow  th by 
50% (IC50: half maximal inhibitory concentration).
Phosphatidylserine externalization analysis of 
promastigotes
The percentages of viable, necrotic, and apoptotic cells were 
determined following treatment for various time points [4, 12, 
18, 24, 36, and 48 hr]. The Annexin-V FLUOS Staining Kit was 
used for the detection of apoptotic and necrotic cells according 
to the manufacturer’s protocol. Briefly, promastigotes were wa-
shed in cold PBS (×2) and centrifuged at 1,400 g for 10 min. 
Then, they were incubated for 15 min in the dark and at room 
temperature in 100 μl of Annexin-V FLUOS in the presence of 
PI (Propidium iodide). Afterwards, the samples were analyzed 
with FACSCalibur flow cytometer (Becton Dickinson and Cel-
lQuest software), and the percentage of positive cells was de-
termined for each sample.
DNA fragmentation assay in the presence and absence 
of miltefosine
Qualitative analysis of total gDNA fragmentation was per-
formed by agarose gel electrophoresis. In short, promastigotes   Khademvatan et al.: Apoptosis of Leishmania by miltefosine   19
(5×10
6 cells) were incubated and harvested in different time 
points. An apoptotic DNA ladder kit was used to extract DNA 
from apoptosis-induced and uninduced cells according to the 
manufacturer’s instructions. DNA (10 μg DNA samples) was 
electrophoresed in 1.5% agarose gels at 100 V for 2 hr, visual-
ized by using a UV transilluminator and photographed.
Promastigote morphology after treatment with HePC
To observe changes in cell morphology, promastigotes treat-
ed with or without miltefosine (IC50), were examined. Cells 
were centrifuged at a low speed (1,000 g) and the pellets sus-
pended in PBS. Changes in morphology were observed under 
×100 objectives on a light microscope. Alteration of cellular 
morphology was studied at different time points, and for each 
sample, at least 10 microscopic fields were observed under× 
100 objectives.
Effects of miltefosine on the cell cycle 
Flow cytometric analysis after cell permeabilization and la-
beling with PI was used to quantify the percentage of pseudo-
hypodiploid cells. Parasites (1×10
6 cells) were treated with an 
IC50 dose of 24, 36, and 48 hr at 24˚C; at each time point, cells 
were fixed in chilled 70% ethanol and kept at -20˚C until anal-
ysis. After washing the cells in PBS, the resultant pellet was re-
suspended in 500 ml DNase-free RNase (200 μg) and incubat-
ed for 1 hr at 37˚C. Cells were then stained with PI (40 μg) and 
incubated in the dark for 20 min at 20-25˚C. Data were oba-
ined using a FACS Calibur and analyzed using the CELLQUEST 
PRO software. 
Statistical analysis
In vitro anti-leishmanial activity was expressed as IC50 (50% 
inhibitory concentration), which was determined by linear re-
gression analysis.
RESULTS
Cytotoxic activity of miltefosine in L. major and L. tropica 
promastigotes
Cytotoxic potential of miltefosine on L. major and L. tropica 
promastigotes was tested using the MTT assay in order to de-
termine 50% inhibitory concentration (IC50) of this drug. The 
viability of treated L. major and L. tropica promastigotes was 
different (Fig. 1). Miltefosine showed a dose-dependent cyto-
toxic effects with almost 100% death at a concentration of about 
24 μM for L. tropica promastigotes. However, for L. major, 100% 
death occurred at a concentration of 32 μM.
In vitro effects of miltefosine in L. major and L. tropica 
amastigotes 
ED50 for L. major and L. tropica amastigotes was determined 
after 48 hr of treatment to different concentrations of miltefos-
ine. The data represent the means±standard deviations (SDs) 
of 3 independent experiments.
The observed ED50 of miltefosine was 5.7 μM and 4.2 μM 
for L. major and L. tropica, respectively. In L. tropica amastigote-
infected macrophages, more than 95% of cells (parasites and 
macrophage) were killed after a 48-hr incubation with 20 μM 
miltefosine. In the case of L. major, after 2 days incubation 80% 
of macrophages and amastigotes were killed.
Morphological changes of treated promastigotes with 
HePc
All tests were performed with Leishmania cultures in the log-
arithmic phase of growth. L. major and L. tropica promastigotes 
were treated with 22 μM and 11 μM miltefosine, respectively. 
The treated and untreated (control) cells were observed with a 
light microscope at 4 hr intervals up to 48 hr. The number of 
promastigotes at the time of drug treatment was 2×10
6/ml. The 
untreated L. tropica control cells continuously grew up to 11-
13×10
6/ml in 48 hr. L. tropica treated cells showed prolifera-
tive activity up to 12 hr post-treatment during which they have 
grown up to 6.0-6.5×10
6/ml in the number. The numbers of 
live promastigotes decreased from 18-48 hr post-treatment 
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Fig. 1. The viability of L. major and L. tropica promastigotes, in 
the presence of various concentrations of HePC, assessed by 
MTT. Each point represents the means of 3 independent tests. 
Dotted line: L. tropica promastigotes, solid line: L. major.20   Korean J Parasitol. Vol. 49, No. 1: 17-23, March 2011
contentiously. L. major treated promastigotes showed prolifera-
tive activity up to 8 hr post-treatment and the numbers of live 
promastigotes decrease from 8-48 hr post-treatment conten-
tiously (Fig. 2).
Microscopic examination of the treated cells showed that 
cell shrinkage started around 4 hr after the drug treatment in 
both L. major and L. tropica promastigotes. Almost all the treat-
ed cells showed cytoplasmic condensation, shrinkage, and re-
duction in size in comparison to the control samples at the end 
of 48 hr after the treatment (Fig. 3).
Phosphatidylserine translocation analysis of treated cells 
with HePC
Flow cytometric analysis of treated L. tropica and L. major 
promastigotes was performed with 24 and 32 μM HePC, re-
spectively, after labeling with Annexin-V FLUOS. In early stages 
of metazoan apoptosis, several alterations happen in the plas-
ma membrane. Translocation of phosphatidylserine from the 
inner side of the cell membrane to the outer side performs one 
of these changes. Fluorescein-conjugated Annexin-V is used to 
detect the externalized phosphatidylserine as it has a high bin-
ding affinity to this phospholipid component. Additionally, 
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Fig. 2. Number of promastigotes treated with or without miltefo­
sine at different time points after 48 hr. Dotted line: L. major (MR­
HO/IR/75/ER) promastigotes and L. tropica (MHOM/IR/02/Mash­
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Fig. 3. Analysis of morphology in light microscopy (magnification, x100) and flow cytometry analysis of L. major and L. tropica pro­
mastigotes following treatment with 22 μM and 11 μM HePC, respectively, at different time points after miltefosine treatment. (A) L. 
major 24 hr after treatment. (B) L. major 48 hr after treatment. (C) L. tropica 24 hr after treatment. (D) L. tropica 48 hr after treatment. 
Lower right region (LR) belongs to apoptotic cells (annexin positive) and upper left region (UL) belongs to necrotic cells (PI positive).  Khademvatan et al.: Apoptosis of Leishmania by miltefosine   21
annexin-V FLUOS allows distinguishing between apoptotic 
cells (annexin V positive, PI negative), necrotic cells (annexin 
positive, PI positive), and surviving cells (annexinV negative, 
PI negative). In the case of L. major promastigotes, after 18 hr 
of incubation 3.2% of the treated cells and 3.0% of the control 
cells were annexin-VFLUOS positive. While, after 24 hr of in-
cubation, annexine-V FLUOS positivity was 16.1% for treated 
L. major promastigotes and 3.5% for the control cells.
After 36 and 48 hr of treatment, the percent of annexin-pos-
itive cells were 37.9% and 73.4%, respectively, whereas the con-
trol group just showed 3.9% for both time points (Fig. 3A). In 
L. tropica promastigotes treated with miltefosine after 18 hr of 
incubation, 14.7% of the treated cells and 3% of the untreated 
cells were Annexin-VFLUOS positive. In the next several time 
points (24, 36, and 48 hr), Annexin-VFLUOS positive cells were 
46.9%, 63.4%, and 90.1%, respectively. In L. tropica, similar to 
L. major in several time points, miltefosine did not show ne-
crosis even after a prolonged incubation, as all the cells remain-
ed negative on PI. In the untreated L. tropica promastigots with 
HePC, Annexin-VFLUOS positive cells were just 3.8% for both 
time points (Fig. 3B). 
DNA fragmentation in L. major and L. tropica 
promastigotes 
DNA fragmentation in promastigotes of L. major and L. trop-
ica was confirmed by the presence of fragmented DNA in aga-
rose gel electrophoresis. The fragments were in oligonucleo-
some size (in approximate multiples of 180-200 bp) in pro-
mastigotes treated with 11 μM HePC for 24 hr in L. tropica, whe-
reas untreated cells did not show DNA fragmentation (Fig. 4). 
No DNA fragmentation was observed in L. major promasti-
gotes treated with 22 μM concentrations of HePC post-24 hr 
incubation. After 36 hr, DNA fragmentation was observed in L. 
major promastigotes. Study of DNA fragmentation in promas-
tigotes of L. tropica promastigotes did not show any difference 
in comparison with L. major after 48 hr.
Miltefosine-induced sub-G0/G1 phase cell-division arrest 
In a given cell, the amount of bound dyes is correlated with 
the DNA content and thus DNA fragmentation in apoptotic 
cells translates into fluorescence intensity lower than that of 
G0/G1 cells, i.e., a sub-G0/G1 peak. In L. tropica promastigotes 
incubated with 24 μM miltefosine for 24 hr, the proportion of 
cells in the sub-G0/G1 phase increased to compare to controls 
(11.5% vs. 3.2%) (Table 1). 
Following 48 hr of HePc treatment, the ratio of promasti-
gotes in the sub-G0/G1 phase increased in comparison to con-
trol cells. In contrast, increase in the number of cells in the 
sub-G0/G1 phase led to a decrease in the cell number in the 
G2/M phase compared with untreated cells. At 24 hr after L. 
major promastigotes were incubated with 32 μM miltefosine, 
the proportion of cells in the sub-G0/G1 phase did not show 
any significant increase in the ratio in comparison to controls. 
Following 48 hr of drug treatment, the ratio of cells in the sub-
G0/G1 phase increased further in comparison to controls. Sim-
ilar to L. tropica, an increase in sub-G0/G1 phase was accom-
panied by a decrease in the number of cells in the G2/M phase 
compared with untreated cells at 48 hr (Table 1). The increased 
ratio of cells in the sub-G0/G1 phase, especially after 48 hr, 
showed that miltefosine apoptosis in L. major and L. tropica 
promastigotes resulted in DNA degradation. 
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Fig. 4. DNA fragmentation detected with agarose gel electro­
phoresis of L. major (right) and L. tropica (left). C, Not treated; 
Lanes 12, 24, 36, and 48 hr incubation periods after treatment 
with miltefosine. Lane M, size marker. 
Table 1. The cell cycle
a of L. tropica and L. major after treatment 
with 24 μM and 32 μM miltefosine for 24 hr and 48 hr, respec­
tively
Species L. tropica (%) L. major (%)
Group sub­G0/
G1 (M1)
G0/G1 
(M2)
G2/M 
(M3)
sub­G0/
G1 (M1)
G0/G1 
(M2)
G2/M 
(M3)
24 hr
   Control   3.2 57.7 39.1   4.1 47.3 48.6
   Treated  11.5 62.7 25.8   6.5 73.3 20.2
48 hr
   Control   3.0 64.9 32.1   3.9 67.0 29.1
   Treated  57.1 32.2 10.7 61.2 25.1 13.7
aMethods for cell­cycle analysis are described in Materials and Methods.22   Korean J Parasitol. Vol. 49, No. 1: 17-23, March 2011
DISCUSSION
CL, due to L. major and L. tropica, is endemic in different 
parts of Iran [10,11]. Different Leishmania species may need to 
various clinical and therapeutic managements in Iran [18,19]. 
Antimonial drug compounds are the first line of treatment of 
CL, but due to side effects, treatment failures and drug resis-
tance, the value of antimony therapy is limited [14,19]. Milte-
fosine is the only oral drug that recently has been developed 
for treatment of leishmaniasis, which is undergoing clinical 
trials in several countries [15]. 
Complications and side effects of miltefosine include nau-
sea and vomiting but not diarrhea, which is considerably less 
than in antimonial drugs [16]. Hadighi et al. [20] showed that 
glucantime-resistant L. tropica isolated from Iranian patients 
with CL are sensitive to alternative anti-leishmania drug. Es-
maeili et al. [21] showed that miltefosine is effective on L. ma-
jor [21]. Mohebali et al. [16], in a randomized clinical trial, 
showed that 2 weeks, 3 months, and 6 months after the end of 
treatment by miltefosine, the clinical outcome is apparently at 
least as good as using meglumine antimoniate for CL caused 
by L. major. Induction of programmed cell death is one of the 
advantages of miltefosine against the other currently used 
drugs, including antimonials [22]. Promastigotes of L. don-
ovani were particularly studied for induction of apoptosis. It 
has been shown that they undergo apoptosis after exposure to 
some agents and nutrient deficiencies that cause programmed 
cell death in higher eukaryotes [17,23]. The process of apopto-
sis shares many similar features in both metazoan and proto-
zoan organisms [7,24]. Two prominent features observed in 
both of these eukaryotes are DNA condensation and fragmen-
tation. 
In the present study, L. major and L. tropica promastigotes 
treated with HePC that both species showed programmed cell 
death features, include cell shrinkage, DNA fragmentation, 
and externalization of phosphatidylserine with preservation of 
integrity of the cell membrane. Similarly, a study was conduct-
ed previously that L. infantum promastigotes exposed to HePC, 
reported a cell death that shares most features associated with 
metazoan apoptosis [25]. 
The DNA content in cells had direct relations with the amo-
unt of fluorescence intensities and in apoptotic cell’s DNA de-
gradation translates into PI intensity lower than G1 cells (sub-
G1 peak). L. tropica promastigotes exposed to 24 μM miltefos-
ine after 24 hr showed that 11.5% of these cells were found in 
the sub-G1 peak region, while in the control group only 4% 
were found in this region (Table 1). Furthermore, L. major pro-
mastigotes treated with 32 μM HePC for 24 hr induced DNA 
degradation. 
Arnoult et al. [22] showed some forms of DNA degradation 
in L. major promastigotes by staurosporine but oligonucleoso-
mal fragmentation was not detected. The typical nuclear fea-
tures, however, has been reported to occur in the amphotericin 
B-treated L. donovani promastigotes [26]. The IC50 is common-
ly used as a measure of drug potency in pharmacological re-
search. In our study, IC50 of HePC on the L. major and L. tropi-
ca promastigotes was determined using MTT assay.
Our results showed that L. tropica promastigotes are more 
sensitive to miltefosine than L. major promastigotes (11 μM vs. 
22 μM). The observed IC50 of HePC on L. tropica (MHOM/
IR/02/Mash10) promastigotes was very close to that on L. in-
fantum (strain MCAN/IR/96/LON49) as reported previously 
[26]. The reported IC50 for 2 different strains of L. donovani was 
different from that of the present study. Different IC50 among 
Leishmania species showed that each organism responds to va-
rious drug concentrations. 
The macrophage-model amastigote cell line was suitable for 
study of the activity of anti-leishmania drugs, which is defined 
as ED50. The observed ED50 of miltefosine for L. major and L. 
tropica amastigotes showed different results, which demon-
strated an intracellular form of L. tropica that is more sensitive 
than L. major to miltefosine. In agreement with this finding, 
Esmaeili et al. [21] reported that Miltefosine has lower ED50 
in L. major infected macrophage than Glucantime (2.20 μM vs. 
7.2 μM). 
In conclusion, HePC may induce L. major and L. tropica apo-
ptotic cell death. The results of the present study about the 
con  centration and time-dependent miltefosine-induced DNA 
frag  mentation were in agreement with other reports [17,27]. 
Interestingly, L. major did not show any apoptotic changes 
when it was exposed to HePC concentrations that is sufficient 
to kill L. tropica. As L. tropica is responsible for residual leish-
maniasis after treatment with glucantime, use of miltefosine 
can be a pro  mising treatment. Better understanding of the 
mechanisms of miltefosine action may help in finding new 
targets for the treat  ment of Leishmania parasites. Finally, our 
findings indicate that HePC may induce dose-dependent apop-
tosis on the causative agent of CL.  Khademvatan et al.: Apoptosis of Leishmania by miltefosine   23
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